TP53 and liver cancer: For example, Sukuma et al. [73] used phage display random peptide technology to screen high-affinity ligand SP94 peptide for HCC (liver cancer cell line) and modified the p53 gene delivery system with this SP94 peptide to achieve a targeted delivery of gene drugs.